The American Cancer Society Cancer Action Network (ACS CAN) and 32 other organizations sent a letter to Congressional leadership urging them to update oversight rules for all diagnostic tests, including laboratory developed tests (LDTs). The groups, which represent patients, scientists, advocates, caregivers, and health care professionals, also want the U.S. Food and Drug Administration (FDA) to play a central role in future oversight of such tests.

Today, the Food and Drug Administration (FDA) issued a proposed rule to limit N-nitrosonornicotine (NNN), a known carcinogen, in smokeless tobacco products. This is the first time FDA has used its authority to require a standard for tobacco products. Under this authority, the FDA can require changes to tobacco products, such as removal of harmful ingredients, elimination of flavors, or reduction of nicotine levels, in order to protect public health.

Today the House took the first step in repealing the Affordable Care Act, following Senate action earlier this week. As the process moves ahead, we urge lawmakers to craft a replacement plan that is immediately available and provides equal or better coverage for cancer patients and survivors.